Viking Therapeutics, Inc.
VKTX
$33.80
-$0.64-1.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -37.89% | -29.22% | -21.81% | -23.20% | -14.28% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -66.57% | 41.50% | 60.11% | 29.37% | 1,939.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -9.21% | -69.77% | 131.67% | 389.08% | 395.88% |
| Total Current Assets | -37.42% | -29.77% | -21.12% | -21.13% | -12.55% |
|
|
|||||
| Total Current Assets | -37.42% | -29.77% | -21.12% | -21.13% | -12.55% |
| Net Property, Plant & Equipment | 414.10% | -- | -91.53% | -40.16% | -20.16% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 500.00% | -57.69% | -54.90% | -63.49% | -60.87% |
| Total Assets | -36.96% | -29.84% | -21.20% | -21.16% | -12.57% |
|
|
|||||
| Total Accounts Payable | 1,156.13% | 772.28% | 442.66% | 1,637.40% | -50.46% |
| Total Accrued Expenses | 55.60% | 244.17% | 36.05% | -14.97% | 90.34% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -65.60% | -- | -71.98% | -8.96% | 40.12% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 242.89% | 443.22% | 179.67% | 1.49% | 27.45% |
|
|
|||||
| Total Current Liabilities | 242.89% | 443.22% | 179.67% | 1.49% | 27.45% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 857.32% | -- | -- | -57.88% | -46.48% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 250.67% | 429.64% | 173.39% | -0.21% | 25.26% |
|
|
|||||
| Common Stock & APIC | 10.66% | 9.27% | 8.57% | 2.95% | 3.25% |
| Retained Earnings | -89.27% | -88.53% | -73.71% | -52.46% | -40.12% |
| Treasury Stock & Other | -594.58% | -296.30% | 147.97% | -77.08% | 92.69% |
| Total Common Equity | -48.67% | -40.74% | -27.40% | -21.77% | -13.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -48.67% | -40.74% | -27.40% | -21.77% | -13.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -48.67% | -40.74% | -27.40% | -21.77% | -13.63% |
|
|
|||||